662 related articles for article (PubMed ID: 25198489)
1. Standardized methodology for transfemoral transcatheter aortic valve replacement with the Edwards Sapien XT valve under fluoroscopy guidance.
Kasel AM; Shivaraju A; Schneider S; Krapf S; Oertel F; Burgdorf C; Ott I; Sumer C; Kastrati A; von Scheidt W; Thilo C
J Invasive Cardiol; 2014 Sep; 26(9):451-61. PubMed ID: 25198489
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement.
Bocksch W; Grossmann B; Geisler T; Steeg M; Droppa M; Jorbenadze R; Haap M; Gawaz M; Fateh-Moghadam S
Catheter Cardiovasc Interv; 2016 Sep; 88(3):466-75. PubMed ID: 27184353
[TBL] [Abstract][Full Text] [Related]
3. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes.
Durand E; Borz B; Godin M; Tron C; Litzler PY; Bessou JP; Bejar K; Fraccaro C; Sanchez-Giron C; Dacher JN; Bauer F; Cribier A; Eltchaninoff H
JACC Cardiovasc Interv; 2012 May; 5(5):461-467. PubMed ID: 22560979
[TBL] [Abstract][Full Text] [Related]
4. First-in-man transfemoral transcatheter aortic valve replacement with the 29 mm Edwards SAPIEN XT valve.
Freeman M; Rodés-Cabau J; Urena M; DeLarochelliere R; Dumont E; Masson JB; Willson AB; Binder RK; Toggweiler S; Leipsic J; Wood DA; Webb JG
Catheter Cardiovasc Interv; 2013 Oct; 82(4):664-70. PubMed ID: 22744829
[TBL] [Abstract][Full Text] [Related]
5. Transfemoral implantation of Edwards Sapien XT aortic valve without previous valvuloplasty: role of 2D/3D transesophageal echocardiography.
García E; Almería C; Unzué L; Jiménez-Quevedo P; Cuadrado A; Macaya C
Catheter Cardiovasc Interv; 2014 Nov; 84(6):868-76. PubMed ID: 24482054
[TBL] [Abstract][Full Text] [Related]
6. The impact of integration of a multidetector computed tomography annulus area sizing algorithm on outcomes of transcatheter aortic valve replacement: a prospective, multicenter, controlled trial.
Binder RK; Webb JG; Willson AB; Urena M; Hansson NC; Norgaard BL; Pibarot P; Barbanti M; Larose E; Freeman M; Dumont E; Thompson C; Wheeler M; Moss RR; Yang TH; Pasian S; Hague CJ; Nguyen G; Raju R; Toggweiler S; Min JK; Wood DA; Rodés-Cabau J; Leipsic J
J Am Coll Cardiol; 2013 Jul; 62(5):431-8. PubMed ID: 23684679
[TBL] [Abstract][Full Text] [Related]
7. The Athens TAVR Registry of newer generation transfemoral aortic valves: 30-day outcomes.
Spargias K; Toutouzas K; Chrissoheris M; Synetos A; Halapas A; Paizis I; Latsios G; Stathogiannis K; Papametzelopoulos S; Zanos S; Pavlides G; Zacharoulis A; Antoniades A; Stefanadis C
Hellenic J Cardiol; 2013; 54(1):18-24. PubMed ID: 23340125
[TBL] [Abstract][Full Text] [Related]
8. Management of paravalvular regurgitation after Edwards SAPIEN transcatheter aortic valve replacement: management of paravalvular regurgitation after TAVR.
Martinez CA; Singh V; O'Neill BP; Alfonso CE; Bilsker MS; Martinez Clark P; Williams D; Cohen MG; Heldman AW; O'Neill WW
Catheter Cardiovasc Interv; 2013 Aug; 82(2):300-11. PubMed ID: 23580318
[TBL] [Abstract][Full Text] [Related]
9. Device success and 30-day clinical outcome in patients undergoing preimplant valvuloplasty in transfemoral versus omitting valvuloplasty in transapical transcatheter aortic valve replacement.
Wong SC; Pawar S; Minutello RM; Horn EM; Skubas NJ; Devereux RB; Salemi A
J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1111-7. PubMed ID: 26277463
[TBL] [Abstract][Full Text] [Related]
10. Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis.
Babaliaros V; Devireddy C; Lerakis S; Leonardi R; Iturra SA; Mavromatis K; Leshnower BG; Guyton RA; Kanitkar M; Keegan P; Simone A; Stewart JP; Ghasemzadeh N; Block P; Thourani VH
JACC Cardiovasc Interv; 2014 Aug; 7(8):898-904. PubMed ID: 25086843
[TBL] [Abstract][Full Text] [Related]
11. Direct transfemoral transcatheter aortic valve implantation without balloon pre-dilatation using the Edwards Sapien XT valve.
Bandali A; Parry-Williams G; Kassam A; Palmer S; Williams PD; de Belder MA; Owens A; Goodwin A; Muir DF
Catheter Cardiovasc Interv; 2016 Nov; 88(6):978-985. PubMed ID: 27189391
[TBL] [Abstract][Full Text] [Related]
12. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).
Généreux P; Cohen DJ; Williams MR; Mack M; Kodali SK; Svensson LG; Kirtane AJ; Xu K; McAndrew TC; Makkar R; Smith CR; Leon MB
J Am Coll Cardiol; 2014 Mar; 63(11):1100-9. PubMed ID: 24291283
[TBL] [Abstract][Full Text] [Related]
13. Feasibility and safety of transfemoral implantation of Edwards SAPIEN XT prosthesis without balloon valvuloplasty in severe stenosis of native aortic valve.
García E; Martín P; Hernández R; Rodríguez V; Fernández A; Gama V; Almería C; Macaya C
Catheter Cardiovasc Interv; 2014 Apr; 83(5):791-5. PubMed ID: 24285561
[TBL] [Abstract][Full Text] [Related]
14. Automated 3D analysis of pre-procedural MDCT to predict annulus plane angulation and C-arm positioning: benefit on procedural outcome in patients referred for TAVR.
Samim M; Stella PR; Agostoni P; Kluin J; Ramjankhan F; Budde RP; Sieswerda G; Algeri E; van Belle C; Elkalioubie A; Juthier F; Belkacemi A; Bertrand ME; Doevendans PA; Van Belle E
JACC Cardiovasc Imaging; 2013 Feb; 6(2):238-48. PubMed ID: 23489538
[TBL] [Abstract][Full Text] [Related]
15. Platelet activation is less enhanced in the new balloon expandable Edwards Sapien 3 valve compared to its predecessor model (Edwards Sapien XT).
Fateh-Moghadam S; Voesch S; Htun P; Jorbenadze R; Geisler T; Gawaz M; Bocksch W
Thromb Haemost; 2016 Jan; 115(1):109-16. PubMed ID: 26311528
[TBL] [Abstract][Full Text] [Related]
16. Transcatheter Aortic Valve Replacement Using Transaortic Access: Experience From the Multicenter, Multinational, Prospective ROUTE Registry.
Bapat V; Frank D; Cocchieri R; Jagielak D; Bonaros N; Aiello M; Lapeze J; Laine M; Chocron S; Muir D; Eichinger W; Thielmann M; Labrousse L; Rein KA; Verhoye JP; Gerosa G; Baumbach H; Bramlage P; Deutsch C; Thoenes M; Romano M
JACC Cardiovasc Interv; 2016 Sep; 9(17):1815-22. PubMed ID: 27609256
[TBL] [Abstract][Full Text] [Related]
17. Commercial versus PARTNER study experience with the transfemoral Edwards SAPIEN valve for inoperable patients with severe aortic stenosis.
Pendyala LK; Minha S; Barbash IM; Torguson R; Magalhaes MA; Okubagzi P; Loh JP; Chen F; Satler LF; Pichard AD; Waksman R
Am J Cardiol; 2014 Jan; 113(2):342-7. PubMed ID: 24220281
[TBL] [Abstract][Full Text] [Related]
18. Transfemoral aortic valve implantation with the repositionable Lotus valve compared with the balloon-expandable Edwards Sapien 3 valve.
Wöhrle J; Gonska B; Rodewald C; Trepte U; Koch S; Scharnbeck D; Seeger J; Markovic S; Rottbauer W
Int J Cardiol; 2015 Sep; 195():171-5. PubMed ID: 26043152
[TBL] [Abstract][Full Text] [Related]
19. Short-Term and Long-Term Outcomes of Patients Undergoing Urgent Transcatheter Aortic Valve Replacement Under a Minimalist Strategy.
Ichibori Y; Li J; Patel T; Lipinski J; Ladas T; Saric P; Kobe D; Tsushima T; Peters M; Patel S; Davis A; Markowitz AH; Bezerra HG; Costa MA; Kalra A; Attizzani GF
J Invasive Cardiol; 2019 Feb; 31(2):E30-E36. PubMed ID: 30700628
[TBL] [Abstract][Full Text] [Related]
20. A Randomized Evaluation of the SAPIEN XT Transcatheter Heart Valve System in Patients With Aortic Stenosis Who Are Not Candidates for Surgery.
Webb JG; Doshi D; Mack MJ; Makkar R; Smith CR; Pichard AD; Kodali S; Kapadia S; Miller DC; Babaliaros V; Thourani V; Herrmann HC; Bodenhamer M; Whisenant BK; Ramee S; Maniar H; Kereiakes D; Xu K; Jaber WA; Menon V; Tuzcu EM; Wood D; Svensson LG; Leon MB
JACC Cardiovasc Interv; 2015 Dec; 8(14):1797-806. PubMed ID: 26718510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
